How Fees Can Enhance FDA’s Role in Ensuring Food Safety

The Food and Drug Administration (FDA) has long been at the forefront of ensuring the safety of food and drugs consumed by the American populace. However, recent analyses have pointed out that the agency’s food oversight capabilities are severely hampered by chronic underfunding and understaffing. This critical situation calls for innovative solutions, such as the introduction of user fees specifically targeted at food industry players. A vibrant discussion surrounding this proposition has been sparked by a recent study published in the journal Health Affairs, which highlights the potential benefits and implications of such a program.

Currently, the FDA manages approximately 78 percent of the U.S. food supply, including an array of packaged products, food additives, and infant formula. The challenges facing the agency in this regard are multifaceted. As the food landscape evolves and grows increasingly complex, the agency’s struggle to maintain adequate oversight becomes ever more pronounced. In light of public health concerns around ultra-processed foods and their additives, the need for a robust regulatory framework for food safety has never been more critical.

A significant aspect of the FDA’s regulatory struggle lies in the way it evaluates food ingredients and additives. While the FDA does enforce guidelines on food and color additives, the industry has access to a loophole known as "generally recognized as safe" (GRAS). This provision allows companies to assert that new substances are safe without the necessity for FDA approval, consequently exposing consumers to potential risks. Alarmingly, recent research indicates that a staggering 99 percent of new ingredients entering the food supply are approved via this GRAS loophole, effectively allowing food companies to self-regulate their products without sufficient oversight.

Experts argue that the proliferation of additives combined with an ever-growing number of self-asserted GRAS substances is eroding the safety and integrity of the food supply. Jennifer Pomeranz, an associate professor of public health policy and management, emphasizes that the FDA desperately needs additional resources to effectively oversee this complicated landscape. Particularly, the need for staff who can diligently assess new ingredients, catch potential hazards before they reach consumers, and ensure food safety standards are met is imperative for public health.

Currently, funding for FDA’s food-related activities primarily comes from congressional appropriations, contrasting sharply with the user fee-based models utilized for drug and tobacco regulation. In 2022, user fees accounted for a remarkable 66 percent of the drug regulation budget, compared to a meager 1 percent for the food program budget. This discrepancy raises questions about the prioritization of food safety within the FDA. Given the direct impact food safety has on public health outcomes, advocates believe establishing a user fee framework for the food industry could not only bolster FDA resources but also foster a more collaborative approach to food safety by engaging stakeholders more closely.

Implementing a user fee program would necessitate Congressional authorization, and such a shift is likely to face initial pushback from industry stakeholders. Nevertheless, history has shown that industries often endorse these programs once they recognize the benefits they bring in terms of faster application reviews and more efficient regulatory processes. The empirical evidence reveals that user fees have significantly accelerated the approval of generic drugs, leading to enhanced market availability and improved consumer access. Similar advantages could be realized within the food sector, creating a more expedient review process for new food products and ingredients.

Highlighting the urgent need for reform, senior author Dariush Mozaffarian argues that the FDA’s current operational model neglects the complexities of food safety regulation. The study posits that increased resources through user fees could empower the FDA to effectively manage the enormous number of food additives and GRAS substances entering the market and close the regulatory gap that permits potentially unsafe ingredients to slip through the cracks.

The dual nature of oversight offered by the FDA—both pre-market approval and post-market review—illuminates another area in desperate need of reform. The agency often misses its own deadlines for reviewing petitions, compounding the backlog of ingredients awaiting approval. Conversely, when it comes to GRAS substances, manufacturers can unilaterally declare ingredients safe, leading to a lack of accountability and transparency in the food supply. The span of time it can take to address safety concerns—like the decades-long process of revoking the GRAS status of partially hydrogenated oils—underscores the urgent need for efficient regulatory mechanisms that can promptly adapt to emerging health information.

The FDA’s post-market review process also faces significant limitations due to inadequate resources, often resulting in delayed interventions even when safety issues are flagged. Such inefficiencies have tangible consequences; for instance, it took over 30 years for the FDA to ban Red No. 3 from foods after acknowledging its dangers. This protracted timeline reveals a concerning trend that can lead to widespread public health repercussions. Advocates stress that bolstering the FDA’s capabilities through user fees could help facilitate swifter actions on unverified ingredients, ultimately safeguarding the public’s health.

While there are promising avenues for improvement, the researchers behind the analysis highlight that increased funding is just one piece of the puzzle. The FDA also requires enhanced authority to prevent unsafe ingredients from entering the food supply in the first place. Strengthening regulations, particularly by closing the GRAS loophole and mandating pre-market notifications of all new ingredients, represents a meaningful starting point for reform. This could be pursued through actions from the FDA itself or new mandates from Congress.

In conclusion, the current gaps in FDA oversight pose significant risks to consumer health and safety. Research underscores the correlation between adequate funding and regulatory efficacy within the realm of food safety. By adopting a user fee framework for the food industry, the FDA could better protect consumers, restore trust in the food supply, and ensure that food safety remains a top priority. The voices of experts and advocates collectively call for reform as a critical step to revamp the FDA’s oversight functions, ultimately leading to a healthier and safer food environment for all Americans.